A carregar...
CAR T Cell Therapy for Solid Tumors: Bright Future or Dark Reality?
Chimeric antigen receptor (CAR) T cell therapy has garnered significant excitement due to its success for hematological malignancies in clinical studies leading to the US Food and Drug Administration (FDA) approval of three CD19-targeted CAR T cell products. In contrast, the clinical experience with...
Na minha lista:
| Publicado no: | Mol Ther |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
American Society of Gene & Cell Therapy
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7647674/ https://ncbi.nlm.nih.gov/pubmed/32979309 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ymthe.2020.09.015 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|